DoubleLock Healthcare, Inc. has completed the proof-of-concept and is developing the patented DoubleLock Sterile Entry Intravenous Port and Syringe System™ which aims to become the new standard-of-care in IV drug delivery by preventing bacterial infection to address this costly HAI issue, delivering 100% compliance with IV port and syring
DoubleLock Healthcare, Inc. has completed the proof-of-concept and is developing the patented DoubleLock Sterile Entry Intravenous Port and Syringe System™ which aims to become the new standard-of-care in IV drug delivery by preventing bacterial infection to address this costly HAI issue, delivering 100% compliance with IV port and syringe tip asepsis and preventing Luer-lock misconnections and wrong-route infusion or injection drug errors.
Prototype #11 is shown in the images.
Contact Us to View
Laboratory Results
Protective cover - No Bacteria; Increased Safety - No Needles; Reduced Legal and Care Costs; Time Savings; Ease of Use; Decreased Toxic Drug Vapors and Leakage; Ensures Compliance with IV Port Asepsis - No Alcohol Swabs or Alcohol Impregnated Caps Needed.
Unique connector to prevent tubing misconnections.
View Demonstration Video